Title of article :
Predictors of Clinical Outcomes in Hemodialysis Patients A Multicenter Observational Study
Author/Authors :
Soleymanian, Tayebeh Nephrology Research Center - Shariati Hospital - Tehran University of Medical Sciences, Tehran, Iran , Niyazi, Hossein Nephrology Research Center - Shariati Hospital - Tehran University of Medical Sciences International Branch, Tehran, Iran , Jafari Dehkordi, Shaghayegh Noorbakhsh Nephrology Research Center - Shariati Hospital - Tehran University of Medical Sciences International Branch, Tehran, Iran , Savaj, Shokoufeh Firouzgar Hospital - Iran University of Medical Sciences, Tehran, Iran , Argani, Hassan Urology and Nephrology Research Center - Modares Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Najafi, Iraj Nephrology Research Center - Shariati Hospital - Tehran University of Medical Sciences, Tehran, Iran
Abstract :
Introduction. Cardiovascular and noncardiovascular mortality
and morbidity rates of hemodialysis patients are high despite
improvement in dialysis delivery.
Materials and Methods. Hemodialysis patients (n = 532) from
9 hemodialysis facilities were enrolled in this cohort study in
September 2012. Causes of death, hospitalization, and hemodialysis
exit were recorded during a 28-month follow-up period. A Cox
proportional hazard model was used to predict death adjusting
for case-mix variables, nutrition variables, bone mineral variables,
Kt/V, vascular access, and Charlson comorbidities index.
Results. Patients were 56.0 ± 15.4 years old (57% men). A total of
161 patients (30%) died (17 per 100 patient years), and the most
common causes of death were cardiovascular diseases (42%) and
infections (25%). Transplantation rate was 7 per 100 patient years
and hospitalization frequency was 0.76 per patient year. Based on
the multivariable Cox proportional hazard model, the mortality
hazard ratio was 1.03 (95% confidence interval [CI], 1.01 to 1.05;
P = .007) for age (years), 0.21 (95% CI, 0.11 to 0.40; P < .001) for
serum albumin (g/dL), 1.21 (95% CI, 1.03 to 1.42; P = .02) for serum
phosphorus (mg/dL), 1.001 (95% CI, 1.0005 to 1.002; P = .001) for
serum intact parathyroid hormone (pg/mL), 1.58 (95% CI, 1.01 to
2.51; P = .047) for hemodialysis catheter (compared to arteriovenous
fistula), and 1.75 (95% CI, 1.59 to 1.94; P < .001) for the Charlson
score.
Conclusions. Nutritional factors, comorbidities, vascular access,
and abnormal mineral metabolism are the main determinants of
mortality and morbidity in hemodialysis patients.
Keywords :
comorbidities , hospitalization , mortality , hemodialysis
Journal title :
Iranian Journal of Kidney Diseases (IJKD)